| Receptor for advanced glycation end products | RAGE |
| Advanced glycation end products | AGEs |
| High-mobility group protein 1 | HMGB1 |
| Amyloid β-protein | Aβ |
| Soluble receptor for advanced glycation end products | sRAGE |
| Endogenous secretory soluble RAGE | esRAGE |
| Nuclear factor kappa-B | NF-κB |
| Mitogen-activated protein kinase | MAPK |
| Systemic lupus | SLE |
| Rheumatoid arthritis | RA |
| Epithelial–mesenchymal transition | EMT |
| Alzheimer’s disease | AD |
| Amyloid prebiotic protein | APP |
| Neurofibrillary tangles | NFTs |
| Macrophage colony-stimulating factor | M-CSF |
| Blood–brain barrier | BBB |
| Endoplasmic reticulum stress | ERS |
| Protein kinase R-like endoplasmic reticulum kinase | PERK |
| Eukaryotic translation initiation factor 2α | eIF2α |
| Binding protein | BiP |
| C Jun N-terminal kinase | cJNK |
| Activating transcription factor 4 | ATF4 |
| Nuclear factor E2-related factor 2 | Nrf2 |
| Kelch-like epichlorohydrin-related protein-1 | Keap1 |
| Glyoxylate 1 | Glo1 |
| Methyl glyoxal | MGO |
| Heme oxygenase 1 | HO-1 |
| Reactive oxygen species | ROS |
| Phosphatidylinositol-3-hydroxylase | PI3K |
| Protein kinase B | AKT |
| Mammalian target of rapamycin | mTOR |
| AMP-dependent protein kinase | AMPK |